Caseware UK (AP4) 2024.0.164 2024.0.164 2025-12-312025-12-31The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.falsetrue2025-01-01falseNo description of principal activity1814true 10781568 2025-01-01 2025-12-31 10781568 2024-01-01 2024-12-31 10781568 2025-12-31 10781568 2024-12-31 10781568 c:Director1 2025-01-01 2025-12-31 10781568 d:OfficeEquipment 2025-01-01 2025-12-31 10781568 d:OfficeEquipment 2025-12-31 10781568 d:OfficeEquipment 2024-12-31 10781568 d:OfficeEquipment d:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 10781568 d:ComputerEquipment 2025-01-01 2025-12-31 10781568 d:ComputerEquipment 2025-12-31 10781568 d:ComputerEquipment 2024-12-31 10781568 d:ComputerEquipment d:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 10781568 d:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 10781568 d:CurrentFinancialInstruments 2025-12-31 10781568 d:CurrentFinancialInstruments 2024-12-31 10781568 d:Non-currentFinancialInstruments 2025-12-31 10781568 d:Non-currentFinancialInstruments 2024-12-31 10781568 d:CurrentFinancialInstruments d:WithinOneYear 2025-12-31 10781568 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 10781568 d:Non-currentFinancialInstruments d:AfterOneYear 2025-12-31 10781568 d:Non-currentFinancialInstruments d:AfterOneYear 2024-12-31 10781568 d:ShareCapital 2025-12-31 10781568 d:ShareCapital 2024-12-31 10781568 d:RetainedEarningsAccumulatedLosses 2025-12-31 10781568 d:RetainedEarningsAccumulatedLosses 2024-12-31 10781568 d:AcceleratedTaxDepreciationDeferredTax 2025-12-31 10781568 d:AcceleratedTaxDepreciationDeferredTax 2024-12-31 10781568 d:OtherDeferredTax 2025-12-31 10781568 d:OtherDeferredTax 2024-12-31 10781568 c:FRS102 2025-01-01 2025-12-31 10781568 c:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 10781568 c:FullAccounts 2025-01-01 2025-12-31 10781568 c:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 10781568 e:PoundSterling 2025-01-01 2025-12-31 iso4217:GBP xbrli:pure

Registered number: 10781568









HUMATICA LIMITED







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 
HUMATICA LIMITED
REGISTERED NUMBER: 10781568

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2025

2025
2025
2024
2024
Note
£
£
£
£

Fixed assets
  

Tangible assets
 4 
21,620
15,914

  
21,620
15,914

Current assets
  

Debtors: amounts falling due within one year
 5 
779,824
1,159,071

Cash at bank and in hand
  
763,110
529,066

  
1,542,934
1,688,137

Current liabilities
  

Creditors: Amounts Falling Due Within One Year
 6 
(705,044)
(941,028)

Net current assets
  
 
 
837,890
 
 
747,109

Total assets less current liabilities
  
859,510
763,023

Creditors: amounts falling due after more than one year
 7 
(77,794)
(88,312)

  

Net assets
  
781,716
674,711


Capital and reserves
  

Called up share capital 
  
10
10

Profit and loss account
  
781,706
674,701

  
781,716
674,711


Page 1

 
HUMATICA LIMITED
REGISTERED NUMBER: 10781568
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2025

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 30 April 2026.




E Datseris
Director

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
HUMATICA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

1.


General information

Humatica Limited is a private company limited by shares and is incorporated in England and Wales. The address of its registered office is 124 Finchley Road, London, NW3 5JS.

The principal activity of the Company during the year was the provision of management consultancy services.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Project revenue

Revenue is recognised in the period in which services are provided under the terms of the engagement. These services are primarily rendered under arrangements that require the client to pay on a fixed-fee basis or based on the period of the engagement. Revenue recognised for services performed and not yet billed to clients are recognised as accrued income. 

Page 3

 
HUMATICA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.4

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the Company in independently administered funds.

 
2.5

Current and deferred taxation

The tax expense for the year comprises current and deferred tax and is recognised in profit or loss.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the Statement of Financial Position date, except that:

- The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and

- Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

Page 4

 
HUMATICA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

The estimated useful lives range as follows:

Office equipment
-
3
to 5 years
Computer equipment
-
3
years

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.7

Debtors

Short term debtors are measured at transaction price, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.9

Creditors

Short-term creditors are measured at the transaction price. 

 
2.10

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Statement of Financial Position when the Company becomes party to the contractual provisions of the instrument.


3.


Employees

The average monthly number of employees, including directors, during the year was 18 (2024 - 14).

Page 5

 
HUMATICA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

4.


Tangible fixed assets





Office equipment
Computer equipment
Total

£
£
£



Cost or valuation


At 1 January 2025
1,386
51,152
52,538


Additions
-
17,094
17,094



At 31 December 2025

1,386
68,246
69,632



Depreciation


At 1 January 2025
216
36,408
36,624


Charge for the year on owned assets
375
11,013
11,388



At 31 December 2025

591
47,421
48,012



Net book value



At 31 December 2025
795
20,825
21,620



At 31 December 2024
1,170
14,744
15,914

Page 6

 
HUMATICA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

5.


Debtors

2025
2024
£
£


Trade debtors
327,550
726,401

Amounts owed by group undertakings
243,808
274,636

Other debtors
26,000
15,743

Prepayments and accrued income
130,052
99,094

Deferred taxation
52,414
43,197

779,824
1,159,071



6.


Creditors: Amounts falling due within one year

2025
2024
£
£

Trade creditors
61,747
145,488

Amounts owed to group undertakings
14,886
157,979

Corporation tax
45,520
68,976

Other taxation and social security
13,591
75,243

Other creditors
11,244
7,237

Accruals and deferred income
558,056
486,105

705,044
941,028



7.


Creditors: Amounts falling due after more than one year

2025
2024
£
£

Accruals and deferred income
77,794
88,312

77,794
88,312


Page 7

 
HUMATICA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

8.


Deferred taxation




2025


£






At beginning of year
43,197


Charged to profit or loss
9,217



At end of year
52,414

The deferred tax asset is made up as follows:

2025
2024
£
£


Accelerated capital allowances
(5,405)
(3,979)

Other timing differences
57,819
47,176

52,414
43,197


9.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £115,730 (2024: £79,750). Contributions totalling £11,131 (2024: £7,158) were payable to the fund at the reporting date and are included in creditors.


10.


Related party transactions

The Company is a wholly owned subsidiary within a group and accordingly has taken advantage of the exemptions provided by "Financial Reporting Standard 102" not to disclose transactions with the entities wholly owned within the group, such as its immediate parent. 

The Company has not entered into any material transactions with related parties that have not been conducted under normal market conditions.

 
Page 8